Altamira Therapeutics Ltd. Proceeds From Borrowings Classified As Financing Activities
Altamira Therapeutics Ltd. (CYTOF) reported Proceeds From Borrowings Classified As Financing Activities of $438.41 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2025-08-29
CHF
| Period end | Proceeds From Borrowings Classified As Financing Activities 6 month | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|---|
| 2023-06-30 | 2.50M CHF 6-K · filed 2023-09-12 | |
| 2022-06-30 | 4.99M CHF 6-K · filed 2023-09-12 | |
| 2018-12-31 | 0.00 CHF 20-F · filed 2019-03-14 | |
| 2017-12-31 | 0.00 CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 11.99M CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |
USD
| Period end | Proceeds From Borrowings Classified As Financing Activities 6 month |
|---|---|
| 2025-06-30 | $438.41K 6-K · filed 2025-08-29 |
| 2023-06-30 | $2.74M 6-K · filed 2024-09-24 |